Ingevity director granted 1,904 deferred stock units
Ingevity director Benjamin G. Wright received an equity grant in the form of deferred stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ingevity director Benjamin G. Wright received an equity grant in the form of deferred stock units. He was granted 1,904 deferred stock units in lieu of the annual non-employee director restricted stock unit grant, at no cash cost per unit. These units will vest on April 30, 2027 and will convert into the same number of Ingevity common shares after his board service ends, under the company’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. Following this grant, he directly holds 11,948 shares.
Insider Trade Summary
Grant/Award: 1,904 shares
Grant/Award
1 txn
Insider
Wright Benjamin G.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,904 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 11,948 shares (Direct)
Footnotes (1)
- F1. Represents a grant of deferred stock units ("DSUs") issued pursuant to the reporting person's election to receive DSUs in lieu of the annual non-employee director restricted stock unit grant. These DSUs will vest on April 30, 2027 and will settle into an equal number of shares of the issuer's Common Stock upon the reporting person's termination of board service pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
Key Figures
Deferred stock units granted: 1,904 units
Shares held after transaction: 11,948 shares
Grant price per unit: $0.0000 per unit
+1 more
4 metrics
Deferred stock units granted
1,904 units
Grant of DSUs in lieu of annual director RSU award
Shares held after transaction
11,948 shares
Direct Ingevity common stock holdings after DSU grant
Grant price per unit
$0.0000 per unit
Non-cash equity award as part of director compensation
Vesting date for DSUs
April 30, 2027
Date when 1,904 deferred stock units vest
Key Terms
deferred stock units, annual non-employee director restricted stock unit grant, Amended and Restated Non-Employee Director Deferred Compensation Plan, 2025 Omnibus Incentive Plan
4 terms
deferred stock units financial
"Represents a grant of deferred stock units ("DSUs") issued pursuant"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
annual non-employee director restricted stock unit grant financial
"in lieu of the annual non-employee director restricted stock unit grant"
Amended and Restated Non-Employee Director Deferred Compensation Plan financial
"pursuant to the issuer's Amended and Restated Non-Employee Director Deferred Compensation Plan"
2025 Omnibus Incentive Plan financial
"and 2025 Omnibus Incentive Plan"
An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ingevity (NGVT) report for Benjamin G. Wright?
Ingevity reported that director Benjamin G. Wright received 1,904 deferred stock units as a grant. These units were taken in lieu of the normal restricted stock unit award and involve no cash payment, functioning as part of his non-employee director compensation package.
What are deferred stock units (DSUs) in Ingevity’s director compensation?
Ingevity’s deferred stock units are share-based awards that track common stock but settle later. For this grant, DSUs vest on April 30, 2027 and then convert into an equal number of common shares only when the director’s board service terminates, deferring receipt of stock.
When do Benjamin G. Wright’s 1,904 Ingevity deferred stock units vest?
The 1,904 deferred stock units granted to Benjamin G. Wright will vest on April 30, 2027. Vesting means the award is earned, but actual common shares are not issued until his board service ends, according to Ingevity’s deferred compensation and incentive plan terms.
Does Benjamin G. Wright pay cash for the 1,904 Ingevity deferred stock units?
No, the grant price per deferred stock unit is recorded as zero, so he does not pay cash for them. The award is part of his non-employee director compensation, replacing the usual restricted stock unit grant structure with deferred settlement in company shares.
Under which Ingevity plans were Benjamin G. Wright’s deferred stock units granted?
The deferred stock units were granted under Ingevity’s Amended and Restated Non-Employee Director Deferred Compensation Plan and its 2025 Omnibus Incentive Plan. These plans govern how director equity awards are granted, vest, and later settle into shares after board service concludes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
